Paroxetine for the prevention of depression induced by interferon alfa.
Kraus
M R
MR
Schäfer
A
A
Scheurlen
M
M
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects*; D003866:Depressive Disorder / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000627:therapeutic use*; D011994:Recombinant Proteins
D018687:Antidepressive Agents, Second-Generation; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D017374:Paroxetine